ONCOassist Deployed in The Clatterbridge Cancer Centre as Enterprise System

Portable Medical Technology LtdPortable Medical Technology and The Clatterbridge Cancer Centre NHS Foundation Trust have announced an enterprise agreement which will see ONCOassist, Portable Medical Technology's revolutionary CE approved software system being deployed as the main oncology decision support system used within Clatterbridge.

ONCOassist was launched in January of last year following extensive development involving oncologists, system developers and compliance personnel in Europe and the United States. Since launch ONCOassist has garnered growing acceptance amongst oncology professionals throughout the UK and Ireland. In August of this year, the platform was offered as an enterprise system. This enables individual trusts and institutions to integrate their guidelines and protocols and make them available throughout the trust in an easy to access and intuitive format across multiple mobile operating systems including iOS, Android and Windows.

The Clatterbridge Cancer Centre, based in Wirral, Merseyside, have been working closely with the ONCOassist team over the past twelve months and an enterprise agreement was the logical next step. "After many discussions with Clatterbridge we realised that, as access to the most up to date version of their protocol library was so important, developing a guidelines and protocols engine that allows for the easy integration and updating of trust specific content that can interact with the many CE approved tools already present on the platform would be of huge benefit," said Eoin O’Carroll of ONCOassist.

Thomas Poulter, Head of IM&T at The Clatterbridge Cancer Centre, said: "Having ONCOassist available in clinics and on the wards will save our clinicians time. The oncology nurses and clinicians will have access to all of the key oncology decision support information and tools they need. For example, our nurses often need to reference protocols or treatment algorithms when delivering chemotherapy treatment. ONCOassist makes it easy to do this."

Jo Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge Cancer Centre, said: "A cancer nurse's role is continually evolving to meet the needs of our patients. Important decisions relating to the management of treatment side-effects and the patient experience of their treatment are fast becoming central to the cancer nurse's role, especially in the outpatient setting. It is essential that vital information to aid decision-making in practice is quick and easy to access. I have found that the ONCOassist app provides easy access to formulas and decision-support information in my day-to-day job."

Kevin Bambury of ONCOassist said: "We are delighted to have The Clatterbridge Cancer Centre as the first NHS trust using our enterprise system. We look forward to working with them over the coming years as we continue to add features and functionality to the system."

About Portable Medical Technology
Portable Medical Technology Ltd develops quality, accredited and trusted apps for medical specialists to reduce medical errors, improve efficiencies and progress patient communication. We combine the essential tools specialists need into a single, easy-to-use smartphone and table application that are FDA and CE approved and provide the latest updated tools to support critical medical decision-making.

Most Popular Now

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...